[S-8] AnaptysBio, Inc. Employee Benefit Plan Registration
AnaptysBio is registering 1,650,000 additional shares of its common stock to be available under the Amended and Restated 2017 Equity Incentive Plan following stockholder approval. The filing makes those shares available for future awards to employees and directors and incorporates prior S-8 registrations and related company filings on file with the SEC.
AnaptysBio sta registrando 1,650,000 azioni ordinarie aggiuntive che saranno disponibili ai sensi del Piano di Incentivazione Azionaria 2017 modificato e riformulato dopo l'approvazione degli azionisti. La comunicazione rende queste azioni disponibili per futuri premi a dipendenti e amministratori e incorpora precedenti registrazioni S-8 e documenti societari correlati depositati presso la SEC.
AnaptysBio est谩 registrando 1,650,000 acciones ordinarias adicionales para que est茅n disponibles en virtud del Plan de Incentivos de Capital de 2017 enmendado y reformulado tras la aprobaci贸n de los accionistas. La presentaci贸n pone esas acciones a disposici贸n para futuras adjudicaciones a empleados y directores e incorpora registros S-8 previos y documentos relacionados de la compa帽铆a presentados ante la SEC.
AnaptysBio電� 欤检＜ 鞀轨澑鞐� 霐半澕 靾橃爼路鞛瀾靹彪悳 2017雲� 欤检嫕 鞚胳劶韹半笇 瓿勴殟 頃橃棎 於旉皜搿� 1,650,000欤检潣 氤错喌欤茧ゼ 霌彪頃橁碃 鞛堨姷雼堧嫟. 頃措嫻 鞁犼碃電� 歆侅洂 氚� 鞚挫偓鞐� 雽�頃� 頄ロ泟 靾橃棳毳� 鞙勴暣 頃措嫻 欤检嫕鞚� 鞚挫毄 臧�電ロ晿瓴� 頃橂┌, 鞚挫爠鞚� S-8 霌彪 氚� 甏�霠� 須岇偓 靹滊毳� SEC鞐� 鞝滌稖霅� 雮挫毄鞙茧 韽暔頃╇媹雼�.
AnaptysBio enregistre 1,650,000 actions ordinaires suppl茅mentaires devant 锚tre mises 脿 disposition dans le cadre du plan d'incitation en actions de 2017 modifi茅 et reformul茅 apr猫s approbation des actionnaires. Le d茅p么t rend ces actions disponibles pour de futures attributions aux employ茅s et administrateurs et int猫gre des enregistrements S-8 ant茅rieurs ainsi que des documents connexes d茅pos茅s aupr猫s de la SEC.
AnaptysBio meldet die Registrierung von 1,650,000 zus盲tzlichen Stammaktien, die nach Zustimmung der Aktion盲re unter dem ge盲nderten und neu gefassten Aktienbeteiligungsplan von 2017 verf眉gbar sein sollen. Die Einreichung stellt diese Aktien f眉r k眉nftige Zuteilungen an Mitarbeiter und Direktoren zur Verf眉gung und nimmt fr眉here S-8-Registrierungen sowie dazugeh枚rige Unternehmensunterlagen auf, die bei der SEC eingereicht sind.
- Stockholder approval of the Amended and Restated 2017 Equity Incentive Plan is recorded in the filing.
- 1,650,000 additional shares of common stock are registered for issuance under the Amended Plan.
- None.
Insights
TL;DR Routine S-8 registration for equity awards; limited immediate financial impact but enables future compensation grants.
This filing registers 1,650,000 additional common shares under the company鈥檚 Amended and Restated 2017 Equity Incentive Plan after stockholder approval. Form S-8 registrations are standard administrative steps that allow the company to grant equity awards; the filing itself contains no new revenue, earnings or debt information and does not change reported financial results.
TL;DR Shareholders approved an amended equity plan and the company completed routine SEC registration and governance steps.
The registration references stockholder approval of the Amended Plan and lists typical exhibits including the amended plan, charter and bylaws, legal opinion and auditor consent. The document also includes powers of attorney and signatures from the CEO, CFO and directors, reflecting standard governance procedures for implementing an equity compensation plan.
AnaptysBio sta registrando 1,650,000 azioni ordinarie aggiuntive che saranno disponibili ai sensi del Piano di Incentivazione Azionaria 2017 modificato e riformulato dopo l'approvazione degli azionisti. La comunicazione rende queste azioni disponibili per futuri premi a dipendenti e amministratori e incorpora precedenti registrazioni S-8 e documenti societari correlati depositati presso la SEC.
AnaptysBio est谩 registrando 1,650,000 acciones ordinarias adicionales para que est茅n disponibles en virtud del Plan de Incentivos de Capital de 2017 enmendado y reformulado tras la aprobaci贸n de los accionistas. La presentaci贸n pone esas acciones a disposici贸n para futuras adjudicaciones a empleados y directores e incorpora registros S-8 previos y documentos relacionados de la compa帽铆a presentados ante la SEC.
AnaptysBio電� 欤检＜ 鞀轨澑鞐� 霐半澕 靾橃爼路鞛瀾靹彪悳 2017雲� 欤检嫕 鞚胳劶韹半笇 瓿勴殟 頃橃棎 於旉皜搿� 1,650,000欤检潣 氤错喌欤茧ゼ 霌彪頃橁碃 鞛堨姷雼堧嫟. 頃措嫻 鞁犼碃電� 歆侅洂 氚� 鞚挫偓鞐� 雽�頃� 頄ロ泟 靾橃棳毳� 鞙勴暣 頃措嫻 欤检嫕鞚� 鞚挫毄 臧�電ロ晿瓴� 頃橂┌, 鞚挫爠鞚� S-8 霌彪 氚� 甏�霠� 須岇偓 靹滊毳� SEC鞐� 鞝滌稖霅� 雮挫毄鞙茧 韽暔頃╇媹雼�.
AnaptysBio enregistre 1,650,000 actions ordinaires suppl茅mentaires devant 锚tre mises 脿 disposition dans le cadre du plan d'incitation en actions de 2017 modifi茅 et reformul茅 apr猫s approbation des actionnaires. Le d茅p么t rend ces actions disponibles pour de futures attributions aux employ茅s et administrateurs et int猫gre des enregistrements S-8 ant茅rieurs ainsi que des documents connexes d茅pos茅s aupr猫s de la SEC.
AnaptysBio meldet die Registrierung von 1,650,000 zus盲tzlichen Stammaktien, die nach Zustimmung der Aktion盲re unter dem ge盲nderten und neu gefassten Aktienbeteiligungsplan von 2017 verf眉gbar sein sollen. Die Einreichung stellt diese Aktien f眉r k眉nftige Zuteilungen an Mitarbeiter und Direktoren zur Verf眉gung und nimmt fr眉here S-8-Registrierungen sowie dazugeh枚rige Unternehmensunterlagen auf, die bei der SEC eingereicht sind.
FAQ
What did AnaptysBio (ANAB) register on this Form S-8?
Which equity plan will receive the newly registered shares?
When was the Amended Plan approved by stockholders?
Does this registration include the Part I information of Form S-8?
What exhibits are included with the registration statement?
